Ann Surg11 Dec 2023
A multicenter retrospective study reports that ultrasound-guided thermal ablation (TA) is an effective and safe treatment option for patients with solitary low-risk papillary thyroid microcarcinoma (PTMC). Over a median follow-up period of 77.2 months, the incidence of disease progression, lymph node metastasis, and recurrent tumors…
Br J Surg4 Dec 2023
In a Swedish cohort of 1636 total thyroidectomy patients, researchers found an alarming 8.7% developed permanent hypoparathyroidism. Notably, 23.2% with low parathyroid hormone levels post-surgery faced a 6.7% risk of permanency. Critically, discrepancies between quality registers and comprehensive chart reviews signal underestimation of the condition's…
BMC Surg4 Dec 2023
In a study spanning 2016 to 2021, 231 patients underwent parathyroidectomy for primary hyperparathyroidism. Preoperatively, 32% had prediabetes, and 47% had insulin resistance. Twelve months postoperative, insulin resistance significantly decreased in both prediabetes (-0.69; p = .04) and insulin resistance groups (-0.85; p < .001).…
BMC Surg27 Nov 2023
Robotic posterior retroperitoneal adrenalectomy and lateral transperitoneal adrenalectomy were compared using a 1:1 matched propensity analysis. In 154 matched cases, no significant differences were found in operative time, conversion to open surgery, postoperative pain, morphine use, length of stay, or 90-day complications. While posterior retroperitoneal…
BMC Surg27 Nov 2023
A study introduced a preoperative calcium challenge for patients with elevated parathyroid hormone and normal calcium levels. Of 29 patients, 55% normalized parathyroid hormone with persistent normocalcemia, confirming secondary hyperparathyroidism. In 19%, classic primary hyperparathyroidism was diagnosed. Short-interval calcium supplementation revealed ∼50% resolved secondary hyperparathyroidism…
Endocrine Surgery26 Nov 2023
In the thyroid cancer arena, the study unveils the tricky identity crisis of anaplastic thyroid carcinoma (ATC). Often emerging from differentiated thyroid carcinoma (DTC), ATC's rebel nature complicates diagnosis. Researchers scoured 36 cases, discovering ATC's deceptive biomarker profile. While TTF1 stays mum, PAX8 and divergent…
BMC Surg26 Nov 2023
Researchers spill the tea on their fresh Enhanced Recovery After Surgery (ERAS) pathway for thyroid/parathyroid surgeries. The vibe? ERAS brings the party with a significant cut in recovery time (9.2 to 7.5 hours) and a drop in patient-initiated admissions. The ERAS group flaunts lower morphine…
Ann Surg Oncol25 Nov 2023
In the quest for parathyroid precision, researchers unveil the potential of near-infrared autofluorescence (NIRAF) overlay imaging. 189 surgical contenders underwent the spotlight, revealing 543 parathyroid glands (PGs). Results? A tiebreaker, with surgeons and overlay imaging each spotting PGs in 111 cases. The NIRAF playbook dictates…
BJS Open24 Nov 2023
In the world of adrenal gland dilemmas, researchers delve into the showdown between total adrenalectomy and its hip sibling, subtotal adrenalectomy, for bilateral pheochromocytoma. Analyzing 10 studies with 1202 patients, they uncover that subtotal adrenalectomy, while saving from adrenal insufficiency, packs a punch with a…
BMC Surg22 Nov 2023
Unveiling the scoop on older adults, researchers spill the tea on dysphagia after thyroid and parathyroid surgery. Surveying 175 patients, aged 65 on average, they found 77.7% reported pre-op swallowing troubles, 22.4% more in frail folks. Post-op, 43.4% and 49.1% faced worse scores at 3…